Menopausal

Menopausal - most related articles:

- Soy isoflavone tablets not reducing bone loss or menopausal symptoms - 3.9
- Exercise reduces menopausal anxiety, stress and depression - 3.8
- Increasing height and body mass index linked to ovarian cancer risk - 3.7
- Heartburn and acid reflex medicines increase hip fracture risk - 3.7
- Acupuncture ineffective in hot flushes during menopause - 3.5
- Antidepressant may reduce menopausal hot flashes - 3.4
- Breast cancer risk increases with high hormone levels - 3.4
- Exercise reduces breast cancer risk - 3.4
- Obesity linked to ovarian cancer risk - 2.8
- Infertility linked to genes for earlier menopause - 2.7

Menopausal articles

Moderate weight loss reduces breast cancer risk
Even a moderate amount of weight loss can significantly reduce levels of circulating estrogens that are associated with an increased risk of breast cancer, revealed by researchers at Fred Hutchinson Cancer Research Center.

Increasing height and body mass index linked to ovarian cancer risk
Increasing height and, among women who have never taken menopausal hormone therapy, increased body mass index are risk factors for developing ovarian cancer in women, revealed by researchers.

Heartburn and acid reflex medicines increase hip fracture risk
Post-menopausal women are 35% more likely to suffer hip fracture if they take indigestion drugs, known as proton pump inhibitors (PPIs), a figure which increases to 50% if they are also current or former smokers.

Red wine drinking may reduce breast cancer risk in women
A glass of red wine with dinner may reduce breast cancer risk in women. Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.

Alcohol increases breast cancer risk in women
Women who consume alcohol show an increase in their risk of developing breast cancer. This relation is stronger for women who drink in binges, are also taking post-menopausal hormonal therapy, and/or have low intakes of dietary folate.

Breast cancer risk increases with high hormone levels
Eight different sex and growth hormones may rise the risk of breast cancer, each elevated hormone level increase risk by 16% in post-menopausal women.

Pfizer new drug could provide a new treatment option for postmenopausal women
Pfizer Inc. will announce new one-year results from the Selective estrogens, Menopause, And Response to Therapy [SMART]-5 Phase 3 study of the safety and efficacy of the investigational tissue selective estrogen complex (TSEC) bazedoxifene/conjugated estrogens (BZA/CE) at the 22nd annual meeting of the North American Menopause Society (NAMS), September_21-24 in Washington, D.C.

Soy isoflavone tablets not reducing bone loss or menopausal symptoms
Soy isoflavone tablets do not appear to reduce bone loss or menopausal symptoms in women within the first five years of menopause, revealed by researchers recently in a study reported in Archives of Internal Medicine.

Facial wrinkles may predict bone density in early menopause
In postmenopausal women the appearance of the skin may offer a glimpse of the skeletal well-being, a relationship not previously described, said Lubna Pal, MD, a reproductive endocrinologist and associate professor at Yale School of Medicine, New Haven, Conn. The worse a woman's skin wrinkles are during the first few years of menopause, the lower her bone density is.

Pfizer drug reduces breast cancer in high risk women
The drug exemestane significantly reduces the risk of breast cancer in high-risk, postmenopausal women is the result of an international, randomized double-blind phase III clinical trial in which University at Buffalo researchers and hundreds of Western New York women played a critical role, revealed at the American Society of Clinical Oncology annual meeting.

Baked or broiled fish lowers heart failure risk
The risk of developing heart failure was lower for postmenopausal women who frequently ate baked or broiled fish, but higher for those who ate more fried fish, in a study reported in Circulation: Heart Failure, an American Heart Association journal.

Breast cancer survivors at higher risk for fractures
The combined effects of chemotherapy and endocrine therapy may increase the risk of bone fractures in breast cancer survivors, revealed by researchers in a study.

Antidepressant may reduce menopausal hot flashes
Women who were either in the transition to menopause or postmenopausal experienced a reduction in the frequency and severity of menopausal hot flashes with the use of the antidepressant medication escitalopram, compared to women who received placebo.

Body fat distribution linked to ER negative breast cancer
Body fat distribution does not play an important role in the incidence of every subtype of premenopausal breast cancer, but is associated with an increased risk for estrogen receptor (ER)–negative breast cancer.

Obesity in colon cancer patients increases mortality
Postmenopausal women diagnosed with colon cancer may be at increased risk of death if they fail to maintain a healthy body weight before cancer diagnosis, revealed by researchers.

Cancer risk found for long-term hormone therapy
Using postmenopausal hormone therapy for more than 15 years increases a woman's risk of developing breast cancer, particularly among leaner women according to research at the Keck School of Medicine of the University of Southern California (USC).

Prolia - new injectable osteoporosis treatment for postmenopausal women
The U.S. Food and Drug Administration approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.

Ulcer medicines may lead to infections and fractures
Proton pump inhibitors, medications that suppress acid in the stomach, appear to be associated with fractures in postmenopausal women and bacterial infections in many patients, and higher doses do not appear any more beneficial for treating bleeding ulcers.

Osteoporosis drugs linked to atypical fractures
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years.

Antidepressants may raise stroke risk in postmenopausal women
Women participating in the Women's Health Initiative study who reported taking an antidepressant drug had a small but statistically significant increase in the risk of stroke and of death compared with participants not taking antidepressants.

Less hormone therapy use in women reduced breast cancer rate
The decreased use of postmenopausal hormone therapy has played a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer, revealed by researchers.

Exercise reduces breast cancer risk
Post-menopausal women who engage in moderate to vigorous exercise and physical activity have a reduced risk of breast cancer, revealed by researchers. Breast cancer is recognized as the most common cancer affecting US women.

Breastfeeding reduces risk of breast cancer
Women with a family history of breast cancer were 59 percent less likely to develop breast cancer themselves if they breastfed their children, revealed by US researchers.

Hormone therapy may increase ovarian cancer risk
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer.

Bone density unnecessary in women taking osteoporosis drugs
Monitoring bone mineral density in postmenopausal women taking osteoporosis drugs (bisphosphonates) is unnecessary and potentially misleading, revealed by researchers through a new study published on bmj.com.

Menopause transition may cause trouble learning
The largest study of its kind to date shows that women may not be able to learn as well shortly before menopause compared to other stages in life. The research is published in the May 26, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology.

HRT-breast cancer risk stays same regardless of family history
The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history, a University of Rochester Medical Center study concluded.

Hormone therapy reduces woman's risk of colorectal cancer by 40%
In a large study, a national team of researchers led by Mayo Clinic scientists observed that self-reported use of hormone therapy was associated with a significantly lower colorectal cancer risk. However, the mechanisms for the apparent protective association are still unclear.

Breastfeeding reduces heart attacks or strokes risks
The longer women breastfeed, the lower their risk of heart attacks, strokes and cardiovascular disease, report University of Pittsburgh researchers in a study published in the May issue of Obstetrics & Gynecology.

Acupuncture ineffective in hot flushes during menopause
Acupuncture cannot be shown to have any positive effect on hot flushes during the menopause.

Blood & ultrasound can diagnose ovarian cancer early
Blood test combined with ultrasound scan can diagnose ovarian cancer (gynecological cancer) early in postmenopausal women, almost 2 years earlier than normal, reported by the British researchers in the Lancet.

Multivitamins offer no benefit in postmenopausal women
The largest study ever conducted on postmenopausal women shows that multivitamins may offer no benefit in reducing the risk of common cancers, cardiovascular disease or overall mortality.

Obesity linked to ovarian cancer risk
A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight.

Diabetes drugs double fractures risk in women
Long term use of a popular class of oral diabetic drugs doubles the risk of fractures in women with type 2 diabetes, revealed by researchers at the Wake Forest University School of Medicine and the University of East Anglia.

Calcium, vitamin D may not reduce breast cancer risk
Taking calcium and vitamin D supplements does not reduce breast cancer incidence in postmenopausal women, according to data from a randomized, doubled-blind, placebo-controlled trial published online November 11 in the Journal of the National Cancer Institute.

Exercise protects against breast cancer
Normal-weight women who carry out lots of vigorous exercise are approximately 30% less likely to develop breast cancer than those who don't exercise vigorously.

Merck's Odanacatib increases bone mineral density
2 year data from a Phase IIB study of odanacatib (formerly MK-0822), an investigational, selective cathepsin-K inhibitor in development for the treatment of osteoporosis by Merck & Co., Inc., demonstrated dose-dependent increases in bone mineral density (BMD) at the total hip, lumbar spine and femoral neck fracture sites and decreased indices of bone resorption compared to placebo in postmenopausal women with low BMD.

Difficulty sleeping increases during menopause
Sleep difficulties, especially problems staying asleep, are relatively prevalent concerns among women going through the menopausal transition, revealed by researchers at Rush University Medical Center in Chicago.

Hormone replacement therapy increases breast cancer recurrence
A new study HABITS revealed that breast cancer survivors who took hormone replacement therapy (HRT) for peri- and postmenopausal symptoms increases disease recurrence than those who did not take HRT.

Overweight, obese women improve life with short exercise
Sedentary, overweight or obese women can improve their quality of life by exercising as little as 10 to 30 minutes a day, researchers reported at the American Heart Association's Conference on Nutrition, Physical Activity and Metabolism.

Combined hormone therapy increases lobular breast cancer risk
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers.

Calcium supplements may increase heart attacks in postmenopausal women
Calcium is an important component of bone, and a sufficient intake of calcium is needed for bone homoeostasis. Calcium supplements can reduce the risk of fractures in elderly women, but high calcium intakes or calcium supplements may increase the risk of heart attack in healthy postmenopausal women.

Exercise reduces menopausal anxiety, stress and depression
With more menopausal women seeking natural therapies to ease symptoms, a new study has found that simply adding a brisk walking routine can reduce a variety of psychological symptoms such as anxiety, stress and depression.

Predicting hip fracture risk in postmenopausal women
To help doctors predict the five-year risk of hip fractures in their postmenopausal patients, a team of UC Davis researchers has developed a method that assesses nearly a dozen factors, including age, ethnicity and level of physical activity.

44 Menopausal articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.34